Eprogen

	Beckman Coulter Announces New Systems Specifically Designed for Protein Discovery
	Business Continues to Grow for Eprogen's Protein Discovery Laboratory
	Eprogen Licenses Protein Mapping Technology to Beckman Coulter as Discussed in Genomika
	Eprogen, Inc. Signs OEM & License Agreement with Beckman Coulter for Proteomics Technology
	Eprogen, Inc. Announced as R&D 100 Award Winner
	Protein Separation Process Could Speed Drug Development, Cancer Research
	Eprogen's ProteoSep™:Shows Promise in the "Fingerprinting" of Bacterial Pathogens
	Eprogen Inc, Offers Considerable Benefits in Drug Discovery with the Introduction of ProteoSep ™
	Eichrom Technologies, Inc announces the formation of EPROGEN, INC, offering innovative technologies in proteomics
	A new test currently under development for the Diagnosis and Monitoring of Bladder Cancer
	New Technology for Bladder Cancer Diagnosis
	Diagnosing Bladder Cancer: Introducing a New Technology
	A New Safeguard Against E. coli
	Eichrom Invents an Easy Way to Identify E. coli O157:H7 in Water Samples
	Eichrom Technologies, Inc. licenses early detection technology for bladder cancer
	Eichrom Announces Availability of a More Specific Test for E. coli Contamination